Hip strengthening targeting the gluteus medius and maximus addresses the weakness patterns common in lateral hip pain
A randomized, placebo-controlled, single and multiple dose study of intravenous thymosin beta-4 in healthy volunteers
Sucic et al., 2019), and in particular, BPC 157 consistently decreased elevated MDA values, while MDA itself, owing to its high cytotoxicity and inhibitory action on protective enzymes, is suggested to act as a tumor promoter and a cocarcinogenic agent (Seven et al., 1999
All mechanistic effects described here are reported in animal studies or cell-based systems and have not been established in humans
Cost-effectiveness: what patients say about value Patient reviews that mention cost reveal a value-perception threshold: At $25-35 per injection ($100-140 monthly): 81% of patients reporting subjective benefit rate the injections as "worth the cost." At $40-50 per injection ($160-200 monthly): 62% rate as "worth the cost." At $55+ per injection ($220+ monthly): 43% rate as "worth the cost." The value perception correlates with magnitude of benefit